Impact of SE of the Proximal Colon on the AMR
Impact of the Second vs. Conventional Examination of the Proximal Colon on Adenoma Miss Rate, a Prospective Randomized Tandem Trial
1 other identifier
interventional
420
1 country
2
Brief Summary
.Studies have demonstrated that the second examination of the proximal colon can significantly increase the proximal ADR.This study aimed to determine the impact of second examination of the proximal colon on AMR compared to conventional examination.Consecutive patients aged 40-75years undergoing colonoscopy for screening.Tandem withdrawal was used in the proximal colon.Patients were randomly assigned to either the second examination(SE) or the conventional examination(CE) group.The primary outcome measure was proximal AMR,defined as the number of proximal adenomas detected in the second pass(CE group)or the third pass(SE group)divided by the total number of proximal adenomas detected during the tandem colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 3, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedFebruary 16, 2023
February 1, 2023
1.8 years
January 25, 2023
February 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
proximal AMR
the number of proximal adenomas detected in the second pass(CE group)or the third pass(SE group)divided by the total number of proximal adenomas detected during the tandem colonoscopy.
2 years
Secondary Outcomes (5)
proximal polyp miss rate
2 years
Per-patient proximal AMR or per-patient proximal PMR
2 years
The adenoma detection rate (ADR) or polyp detection rate (PDR)
2 years
Adenoma per colonoscopy (APC) or polyp per colonoscopy (PPC)
2 years
proximal advanced AMR(AAMR)
2 years
Study Arms (2)
conventional examination
NO INTERVENTIONFor patients in the CE group, the colonoscope was withdrawn directly from the splenic flexure to the rectum, and polyps that were found were removed
second examination
EXPERIMENTALFor patients in the SE group, the colonoscope was reinserted into the cecum, additional polyps were removed from the proximal colon during the third withdrawall(third pass), and the remainder of the colon from splenic flexure to rectum was examined in a standard manner
Interventions
For patients in the SE group, the colonoscope was reinserted into the cecum, additional polyps were removed from the proximal colon during the third withdrawall(third pass), and the remainder of the colon from splenic flexure to rectum was examined in a standard manner
Eligibility Criteria
You may qualify if:
- Consecutive patients aged 40-75years undergoing colonoscopy for screening
You may not qualify if:
- failed cecal intubation, prior colorectal resection, inadequate bowel preparation quality (Boston Bowel Preparation Scale (BBPS)scores \< 2 in any segment of the colon), inflammatory bowel disease or intestinal tuberculosis, familial polyposis syndrome, coagulation dysfunction, or polyp retrieval failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Second People's Hospital of Jingdezhen City
Jingdezhen, Jiangxi, 333000, China
Third People's Hospital of Jingdezhen City
Jingdezhen, Jiangxi, 333000, China
Study Officials
- STUDY DIRECTOR
li yang
Third People's Hospital of Jingdezhen,
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 3, 2023
Study Start
February 15, 2023
Primary Completion
December 15, 2024
Study Completion
December 30, 2024
Last Updated
February 16, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share